HCPCS Level II · Drugs administered other than oral method
J2995Injection, streptokinase, per 250,000 iu
Terminated 12/31/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2995
J2995 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, streptokinase, per 250,000 iu.
It was added to HCPCS effective 01/01/1986, and its current record took effect 01/01/2026.
It was terminated on 12/31/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj streptokinase /250000 iu
- Date added
- 01/01/1986
- Action effective
- 01/01/2026
- Termination date
- 12/31/2025
- BETOS
- O1E
Related J29xx codes
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919Injection, methylprednisolone sodium succinate, 5 mg
- J2941Injection, somatropin, 1 mg
- J2950Injection, promazine hcl, up to 25 mg
- J2993Injection, reteplase, 18.1 mg
- J2997Injection, alteplase recombinant, 1 mg
- J2998Injection, plasminogen, human-tvmh, 1 mg
Common questions about J2995
Is HCPCS J2995 still valid?
- No. J2995 was terminated on 12/31/2025.
Does Medicare cover J2995?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.